Amniotic fluid embolism: Pathophysiology from the perspective of pathology

J Obstet Gynaecol Res. 2017 Apr;43(4):627-632. doi: 10.1111/jog.13284. Epub 2017 Feb 11.

Abstract

Amniotic fluid embolism (AFE) is recognized as a type of syndrome characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC), occurring during labor, delivery, or immediately postpartum, caused by the inflow of amniotic components into the maternal circulation. AFE is a rare condition but one of the most serious obstetrical complications, resulting in a high mortality rate among pregnant women. Despite earlier recognition and intensive critical management, we often encounter patients who unfortunately do not recover from the exacerbation of AFE-related conditions. A major concern is that there are no effective evidence-based therapies for AFE, because its pathophysiology is still not well understood. This article reviewed AFE, focusing on the pathology and currently proposed pathophysiology.

Keywords: amniotic fluid embolism; anaphylactoid reaction; disseminated intravascular coagulopathy; postpartum acute myometritis; postpartum hemorrhage; uterine atony.

Publication types

  • Review

MeSH terms

  • Embolism, Amniotic Fluid* / pathology
  • Embolism, Amniotic Fluid* / physiopathology
  • Embolism, Amniotic Fluid* / therapy
  • Female
  • Humans
  • Pregnancy